SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Technology Stocks : Safeguard Scientifics SFE -- Ignore unavailable to you. Want to Upgrade?


To: John Arnopp who wrote (1257)3/20/1998 11:05:00 PM
From: William R. Polk  Read Replies (1) | Respond to of 4467
 
John: I read a post on Yahoo the other day that suggested that SFE was trading much closer to current NAV because of the fact that there are some $91 million in notes which are convertible into common at $28.985. If these were converted it would add approximately 2.6 million shares. I'm not sure at this point whether the # of shares you (we) are using included the dilutive effect of these shares. Do you know? Anyway here is the blurb on the Notes from last year's 10K:

<<In February 1996, Safeguard completed the private placement of $115 million of 6% Convertible Subordinated Notes ("Notes") due February 1, 2006 to J.P. Morgan Securities, Inc. J.P. Morgan resold the Notes to institutional buyers and in offshore transactions. The Notes are convertible into Safeguard Common Stock at $28.985 per share. As of March 1997, approximately $24 million of the Notes had been converted into approximately 832 thousand shares of common stock.>>



To: John Arnopp who wrote (1257)3/24/1998 6:19:00 AM
From: Timothy R. West  Read Replies (2) | Respond to of 4467
 
Does SFE have any bank debt to finance its repurchases or to finance its current holdings? If so, we need to deduct the debt in the NAV calculation. Does anyone have brokerage accounts at any of the firms listed on their "analyst coverage" page at safeguard.com If not, one of us should open an account at each firm so we can get the research reports to share here?

Anyone care to jump in?

Best,

Tim West